Active ingredientBendroflumethiazideCat. No. P-B028-001CAS 73-48-3Family · Pharmaceutical analytical standards
Bendroflumethiazide
A thiazide diuretic patented in 1958 and approved for medical use in 1960, used mainly for high blood pressure and, in some cases, for mild heart failure. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was once called bendrofluazide; it blocks sodium reabsorption in the kidney, but part of its effect on blood pressure also comes from widening of the blood vessels.
Go to the active ingredient →Active ingredientBendroflumethiazideCat. No. P-B028-001CAS 73-48-3
Pharmacopoeial impurityBendroflumethiazide EP Impurity ACat. No. P-B028-002CAS 654-62-6
Isotopically labelledBendroflumethiazide-d5Cat. No. P-B028-003CAS 1330183-13-5
NitrosamineN-Nitroso BendroflumethiazideCat. No. P-B028-004
Impurity(R)-BendroflumethiazideCat. No. P-B028-005CAS 1087345-31-0
Impurity(S)-BendroflumethiazideCat. No. P-B028-006CAS 1245935-40-3No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
ImpurityBendroflumethiazide impurity A CRSEDQM code Y0000564Family BendroflumethiazideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.